• Pharma Equity Group resolved on November 9, 2026, to issue up to DKK 4.13 million in convertible loans.
• The financing includes repayment of DKK 2 million issued April 1, 2025, and DKK 880,592 issued December 1, 2025.
• The new loans carry 10% annual interest and convert at DKK 0.1 per share.
• Conversion rights run for 30 days from the start of month 23; the company can extend the loan period by 12 months.
• Unconverted principal and accrued interest will be redeemed in shares; conversion could increase nominal share capital by up to DKK 5.43 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Equity Group A/S published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.